Steven Austad

Austad articulates a credible, durable geroscience vision centered on understanding aging well enough to develop interventions that slow age-related health decline. He also identifies practical requirements for progress, including reliable health assays, standardized outcome measures, and separate evaluation of lifespan, healthspan, and morbidity. However, the evidence does not show a specific development roadmap, timeline, intervention target, or consistent commitment to ending aging or reversing decline.

Strong, independently corroborated scientific influence in comparative biology and aging. An h-index of 66, more than 16,000 citations, and multiple papers with several hundred to nearly 1,800 citations indicate sustained agenda-setting impact across aging evolution, sex differences in lifespan, telomeres, and comparative mammalian longevity.

The evidence establishes Austad's scientific output but identifies no investments, donations, investees, disclosed capital, catalytic positions, or capital-backed longevity outcomes. Capital deployed is therefore genuinely inapplicable on the supplied record.

No public capital deployment activity is evidenced for this academic scientist.

Austad shows a sustained, thesis-coherent commitment to comparative and evolutionary biology as a way to uncover determinants of aging. His early studies of unusually long-lived mammals and populations plausibly represented a distinctive research bet and became influential. However, the supplied evidence does not establish explicit counterfactual importance, unusual risk-taking, precise strategic choices among alternatives, or that his work opened paths others were not pursuing.

Field creation is applicable, but the supplied evidence establishes scholarly contributions rather than the creation of organizations, programs, categories, communities, protocols, or funding paths. The structured facts explicitly report no founded organizations or donation-created programs.

The dimension is applicable, but the supplied evidence documents a substantial conventional research career rather than public risk-taking or costly conviction. None of the five qualifying bravery flavors is established.

Austad shows meaningful second-order influence through a large, highly cited research portfolio and collaborations spanning multiple institutions and comparative-aging topics. This suggests his work has shaped subsequent scholarship and attracted collaborators, but the supplied evidence does not demonstrate organization-building, talent pipelines, capital mobilization, policy influence, public legitimacy gains, or identifiable follow-on initiatives at a scale supporting a higher score.